GC WellBeing
녹십자웰빙 · 234690
Health Care Pharmaceuticals · KOSDAQ
Market cap US$116.1M (₩160.2B)
Overview
GC WellBeing makes injectable vitamins, minerals, and specialty prescription drugs, such as a human placenta extract and a tissue-regenerating pain-relief injection, that clinics and hospitals administer directly to patients.
It also supplies a clinic-exclusive line of oral health supplements, including vitamins and probiotics, under the Dr.PNT brand, as well as aesthetic medical devices such as skin boosters and fillers. Listed on KOSDAQ, Korea's tech and small-cap board, its prescription injectable nutrition products form the core of its business, with clinics and pharmaceutical wholesalers as its primary distribution channels.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$87.3M
- FY2024US$97M
- FY2025US$119.3M
Operating profit
- FY2023US$7.6M
- FY2024US$9.4M
- FY2025US$12.5M
Net income
- FY2023US$4.9M
- FY2024US$5.1M
- FY2025US$7.3M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?